Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative parenteral nutrition with SMOF versus Intralipid in elderly gastric cancer patients at nutritional risk
ChiCTR-IPR-15007557Phase 4Completed
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Jan 2014
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of SMOFlipid and Intralipid 10% in gastric cancer (GC) (3 arms), sponsored by The First Hospital of Fujian Medical University. Primary endpoints: albumin, prealbumin and 10 more. Started Jan 2014; status: completed.
02
Drugs
SMOFlipidIntralipid 10%
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR-IPR-15007557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007557.